M1 Kliniken AG (ETR:DE000A0S) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
M1 Kliniken AG

BRIEF

published on 05/21/2025 at 08:35, 6 months 14 days ago

M1 Kliniken AG Reports Strong 2024 Earnings Growth

Cash Flow Profitability Dividend Policy Earnings Growth Beauty Segment
PRESS RELEASE

published on 05/21/2025 at 08:30, 6 months 14 days ago

M1 Kliniken AG: Strong Earnings Growth in 2024 – Strategic Focus on Global Market Leadership
M1 Kliniken AG reports strong earnings growth in 2024, focusing on global market leadership. Annual report shows revenue and profit increase, affirming dividend policy

Financial Report M1 Kliniken AG Dividend Policy Global Market Earnings Growth
BRIEF

published on 04/29/2025 at 08:35, 7 months 5 days ago

M1 Kliniken AG Reports Strong Financial Growth in 2024

Earnings Per Share Market Expansion Financial Stability EBIT Growth Beauty Treatments
PRESS RELEASE

published on 04/29/2025 at 08:30, 7 months 5 days ago

M1 Kliniken AG publishes preliminary figures for the 2024 financial year: Strong EBIT growth (+70%) and significant increase in earnings per share (+57%)
M1 Kliniken AG reports strong growth in EBIT (+70%) and earnings per share (+57%) for 2024. Revenue up by 7%, expansion of clinics, and optimistic outlook for 2025

Financial Results M1 Kliniken AG Earnings Per Share EBIT Growth Clinic Expansion
BRIEF

published on 04/01/2025 at 17:18, 8 months 3 days ago

M1 Kliniken AG: HAEMATO AG Considers Sale of Trading Segment

M1 Kliniken AG Strategic Focus Beauty Business HAEMATO AG Trading Segment
PRESS RELEASE

published on 04/01/2025 at 17:13, 8 months 3 days ago

EQS-Adhoc: M1 Kliniken AG: HAEMATO AG is reviewing an offer for the sale of its trading segment
HAEMATO AG, majority-owned by M1 Kliniken AG, reviews Conditional Binding Offer for sale of trading segment. Focus on beauty business. Further updates awaited

M1 Kliniken AG Strategic Focus Beauty Business HAEMATO AG Conditional Binding Offer
BRIEF

published on 12/17/2024 at 12:06, 11 months 18 days ago

M1 Kliniken AG Maintains Strong Performance in Q3

Buy Recommendation M1 Kliniken AG Q3 Performance Beauty Segment Growth Price Target €28
PRESS RELEASE

published on 12/17/2024 at 12:01, 11 months 18 days ago

Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research has published a research update on M1 Kliniken AG, reaffirming a BUY rating with a target price of €28. The thriving Beauty business drove revenue and profit growth in Q3

M1 Kliniken AG BUY Rating Research Update Target Price Beauty Business
BRIEF

published on 11/19/2024 at 08:20, 1 year ago

M1 Kliniken AG Reports 71% Increase in Operating Profit

Private Equity Operating Profit Beauty Segment Financial Growth Strategic Expansion
PRESS RELEASE

published on 11/19/2024 at 08:15, 1 year ago

M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets
M1 Kliniken AG reports a 71% increase in operating profit (EBIT) in the first nine months of 2024, with sales up by 8.7%. Medium-term targets confirmed

Operating Profit M1 Kliniken AG Sales Increase Medium-term Targets Beauty Treatments

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 19 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 24 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 54 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 49 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 54 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 24 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 3 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 29 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 39 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 44 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 54 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 9 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 10 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 53 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE